With increasing antibiotic resistance, bacterial infections remain an important threat to human health. To identify novel targets for therapeutic intervention our group investigates host-bacteria interactions by innovative mass spectrometry (MS)-based approaches. Using Listeria monocytogenes as an intracellular bacterial model pathogen, we focus on the analysis of ubiquitin-like protein modifications of the immune system and the MS-based identification of novel bacterial antigens.